In the future digital transformation of the pharmaceutical industry, how should pharmaceutical companies plan to achieve sales growth?
Over 30 exhibitors, with a year-on-year sales growth of over 300%
On August 5, the first JD Health "Yunshang Medicine Fair" hosted by JD Health's drug wholesale trading platform "JD Medicine Jingcai" closed. In the three-day online exhibition, more than 300 pharmaceutical companies participated in the exhibition, hundreds of thousands of people in the pharmaceutical industry visited the "cloud exhibition" and watched live broadcasts. Sales of more than 30 exhibitors increased by more than 300% year-on-year.
During the conference, JD Pharmaceuticals Jingcai signed a series of strategic contracts with many partners covering all links of the pharmaceutical industry chain. At the same time, exhibitors received more than 50,000 negotiation invitations. The Cloud Pharmaceutical Fair helps pharmaceutical companies realize closed-loop transactions from participation to order conversion. This action also promotes the acceleration of the digital transformation of the traditional pharmaceutical industry.
As a pharmaceutical exhibition that accompanies the development of China's pharmaceutical industry, it has been taking on the role of the "service supply chain" of pharmaceutical companies for many years, but for a long time, traditional offline pharmaceutical exhibitions have faced short cycles and it is difficult for exhibitors to directly transform from participation to transaction. Due to the predicament and the impact of the epidemic, most offline pharmaceutical exhibitions face the risk of delay or even cancellation. From cautious attempts to online exhibitions, the pace of digitalization has also accelerated greatly.
Earlier, the "Notice on Innovating Exhibition Service Models and Cultivating New Drivers of Exhibition Industry Development" issued by the General Office of the Ministry of Commerce mentioned that it is necessary to actively guide, mobilize and support enterprises to hold online exhibitions and make full use of 5G, VR/AR , Big data and other modern information technology means, hold "cloud exhibition", carry out "cloud exhibition", "cloud docking", "cloud negotiation", "cloud signing". The first JD Health "Cloud Pharmaceutical Fair" was held based on this background, creating a matrix consisting of "Cloud Pharmaceutical Fair APP + Mini Program + Website", and building a "Cloud Exhibition Center" for enterprises without leaving home. Remote participation.
At the same time, through innovative methods such as 3D VR exhibition halls, live broadcast rooms, online negotiation rooms, and real-time chat tools, it breaks the venue restrictions of traditional offline medical exhibitions and provides exhibitors with a full range of display channels, which is convenient for exhibitors and buyers. Conduct online negotiations, let the industry directly reach the terminal, and promote the digital transformation of the pharmaceutical industry.
How to make industry reach the terminal directly?
In the pharmaceutical e-commerce business, pharmaceutical logistics is the most critical part. As a special commodity, the state has put forward very high requirements for its storage management, transportation and distribution. The drug regulatory department believes that "the management level and conditions of ordinary express companies do not meet the quality requirements of drug delivery, the risks of express drugs in transit are difficult to control, and it is difficult to define responsibilities for drug quality problems." The draft of the new "Measures for the Supervision and Administration of Drug Operations" requires that third-party drug logistics companies must meet GSP requirements and requirements for personnel, data docking and recording, and facilities and equipment.
In the current pharmaceutical logistics structure, there are mainly three forces of traditional pharmaceutical distribution companies, third-party logistics companies such as JD.com, and instant delivery new business. At the same time, Yaojingcai provides an integrated service platform of all categories, all links and all channels for the pharmaceutical industry.
Zhou Xinyuan, general manager of JD Health Channel Innovation Department and head of Yaojingcai said, "By providing digital empowerment solutions for the industrial, commercial, and terminal links of pharmaceutical circulation, Yaojingcai has opened up the entire pharmaceutical B2B link, and the transaction volume has increased within 3 years. 28 times, of which 180,000+ downstream customers, 40%+ active users, 200+ commercial companies settled in, and 300+ city coverage was achieved.
Pharmaceutical Capital: Upstream pharmaceutical companies, downstream pharmacies
Pharmaceutical Jingcai is a B2B platform of JD Health and Medicine. The upstream connects medical industrial enterprises and commercial enterprises, and the downstream connects medical institutions such as terminal pharmacies, independent clinics, and village clinics. It aims to solve the pain points of high cost, information blockage, and low efficiency in the traditional medicine circulation field.
It is understood that Yaojingcai uses industrial resources to feed back, JD’s logistics assistance, terminal resource capture, and JD’s financial blessing to empower all aspects of pharmaceutical circulation; and through drugs, non-pharmaceuticals, pharmaceutical + insurance solutions, pharmacies, etc. The terminal link provides product + service empowerment; at the same time, it provides data management for upstream and downstream based on information and behavior labels such as services, LBS, RFM, and life cycle. In the pharmaceutical circulation terminal and the user link, through the JD Health-Alliance Pharmacy, we will create a health steward for the common people.
Zhou Xinyuan introduced, “First, through operation standardization and supply chain finance, we will help the terminal to complete the basic capacity building, and then through the Internet digital operation to realize the terminal capacity upgrade, and finally realize the chief health steward function integrating chronic disease management, health consultation, and health inspection. ."
Some people in the industry also pointed out that JD Health runs through the user's "service supply chain" before, during and after the diagnosis, and it has become a necessary condition for accelerating the digital transformation process of the traditional pharmaceutical industry in realizing the transformative value of "Internet +" in the field of pharmaceutical circulation. dvd.com.cn/china.org/cn/index.php?
After the "Yunshang Pharmaceutical Fair" APP and Yaojingcai APP are opened, the effect is even more obvious. From the situation of the exhibition alone, the number of exhibited products exceeds 50,000, and the main promotion of new products exceeds 2500. During the conference, JD Health and JD Allianz P&C reached a strategic cooperation to build a health insurance service supply chain and comprehensively promote the integrated development of “health insurance + health services”; A series of strategic signings were signed by partners such as Park Trade, Xiangdanqing, Shangyizhixin, and Gerui Health Technology.
It can also be seen from the above layout that under JD’s health layout, the whole chain of pharmaceutical circulation will promote the professionalization, digitalization and intelligent and efficient integration of resources in the pharmaceutical industry, and in the process of creating a convenient, efficient, and intelligent pharmaceutical industry chain. Cai Cai has always been playing an important role in the circulation of medicines, and this "Medicine Fair on Cloud" can also be seen that its service capabilities and experience are mature enough. We also expect that Yaojingcai will play a greater role in the new changes in the circulation of new medicines in the future.